Simplifying Global Compliance
FDAnews Drug Daily Bulletin
ANTISENSE PHARMA RAISES $ 18 MILLION IN VENTURE FINANCING
Dec. 1, 2005
Antisense Pharma announces today that it has raised $ 18.0 million in private
equity from the German MIG funds. This investment further validates Antisense
Pharma's worldwide leadership in the field of antisense technology and its application,
the development of targeted anticancer drugs.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing